Innovation, Commercialization, and Start-Ups in Life Sciences - Image 1

£61.74

CRC Press Innovation, Commercialization, and Start-Ups in Life Sciences

Name: Innovation, Commercialization, and Start-Ups in Life Sciences
Brand: CRC Press
Price: 57.89 GBP
Availability: InStock

Management Science

Price History & Forecast

Last 77 days • 77 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 77 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £58 (76 days, 98.7%)

Price range: £58 - £62

Price levels: 2 different prices over 77 days

Description

Innovation is a translation of a new method, idea, or product into reality and profit. It is a process of connected steps that accumulates into a brand reputation required for success. Unlike Fortune 500 companies, whose projects are self-funded, a start-up must simultaneously have a value proposition that attracts a customer (for revenue), investors (for capital), and acquirers (for a liquidity event or IPO). A high percentage of start-ups fail before attaining positive cashflow, due to a variety of reasons that are detailed in this book. Avoiding the pitfalls and wrong turns are the goals of this book. Innovation, Commercialization, and Start-Ups in Life Sciences details the methodologies necessary to create a successful life science start-up from initiation to exit. Written by an expert who has worked with more nearly 500 life science start-ups, this book discusses specific processes and investor milestones that must be navigated to align customer, funder, and acquirer needs. Successful commercialization requires attention to multiple constituents, such as investors, regulators, and customers. Investors require liquidity for their return, which is achieved through selling their stock in a public or private sale. The reader will gain an appreciation for the necessary data, partnerships, and skills needed to create a competitive and sustainable company. The author discusses such specific issues as customer problems, demonstrating sales access, and ensuring intellectual property is impervious to competitive advancement. This book is intended to be suitable for entrepreneurs, venture capitalists, and investors in both business and academic settings. These organizations have specific departments, such as R&D, operations, business development, legal, regulatory, and marketing, that would also benefit from this book. FEATURES Focuses specifically on life science start-ups Examines how to determine a company valuation and future "fundable milestones" Explores how to align regulatory and clinical strategies Discusses intellectual property derived from a university or individual through formation to exit. Reviews how start‐ups must simultaneously meet the needs of multiple constituencies at once: investors, regulators, customers and exit candidates James F. Jordan is an author, consultant, and speaker. He is a Distinguished Service Professor of Healthcare & Biotechnology Management, a former Fortune 100 executive, and a managing director of a venture fund. Access the Support Material: https://healthcaredata.center/ Cover design by Sarah Mailhott.

Product Specifications

Brand: CRC Press
Format: paperback
ASIN: 0367533049
Category: Books > Subjects > Business, Finance & Law > Management > Management Science
Domain: Amazon UK
Release Date: 28 September 2021
Listed Since: 02 April 2021

Barcode

No barcode data available

CRC Press Innovation, Commercialization, and Start-Ups in Life Sciences

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Geschäftsmodelle für Inkubatoren: Strategien, Konzepte, Handlungsempfehlungen (Innovation und Technologie im modernen Management)

Forschung wider Willen?: Rechtsprobleme biomedizinischer Forschung mit nichteinwilligungsfähigen Personen (MedR Schriftenreihe Medizinrecht)

Transparency in Health and Health Care in the United States: Law and Ethics

The 2027-2032 World Outlook for Biotechnology and Pharmaceutical Consulting Services

The Use of Human Beings in Research: With Special Reference to Clinical Trials: 28 (Philosophy and Medicine, 28)

The Freedom of Scientific Research: Bridging the Gap Between Science and Society (Contemporary Issues in Bioethics)

The Health Care Dilemma: A Comparison of Health Care Systems in Three European Countries and the US

Valuepack: Biology: International Edition/Practical Skills in Biology

Computational Bioengineering and Bioinformatics: Computer Modelling in Bioengineering: 11 (Learning and Analytics in Intelligent Systems, 11)

Advances in Immunology (Volume 135)

Endotoxin Detection and Control in Pharma, Limulus, and Mammalian Systems

Toxicological Aspects of Medical Device Implants

Reshaping Healthcare with Cutting-Edge Biomedical Advancements

Undue Risk: Secret State Experiments on Humans

Recoding Life: Information and the Biopolitical

Enhancing the Professional Culture of Academic Health Science Centers: Creating and Sustaining Research Communities (Culture, Context and Quality in Health Sciences Research, Ed)

Davidson's Principles and Practice of Medicine

Génétique médicale: De la biologie à la pratique clinique

Recent Advancements in Microbial Diversity: Macrophages and their Role in Inflammation (Woodhead Publishing Series in Composites Science and Engineering)

Beyond Growth Hacking: Mastering Business Model Evolution (Managing Innovation in Business Strategy, Marketing and Finance)

Health Professional and Patient Interaction

Functional Proteomics: Methods and Protocols: 1871 (Methods in Molecular Biology, 1871)

The 2027-2032 World Outlook for Biotechnology Reagents

Dynamic Capabilities als Einflussfaktoren des Markteintrittstimings: Modellierung und empirische Analyse am Beispiel von B2C-Start-up-Unternehmen im ... Markets and Organisations)